Galera Therapeutics increased authorized common stock from 200 million to 400 million shares and granted stockholders right to act by written consent via charter amendments approved by shareholders on May 8, 2026.
Key takeaways
Authorized common shares doubled from 200 million to 400 million via Stock Increase Charter Amendment filed May 11, 2026.
Written Consent Charter Amendment filed May 12, 2026, allows stockholder actions by written consent without meetings.
Both charter amendments approved by stockholders at Annual Meeting on May 8, 2026.
Board adopted Amended and Restated Bylaws on May 12, 2026, effective immediately, implementing written consent procedures.
Exhibits 3.1, 3.2, and 3.3 contain full texts of amendments and bylaws.